论文信息 - A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study - 字舞流文

A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study

Y. Okabe | M. Shimokawa | T. Otsuka | K. Mitsugi | S. Arima | Y. Kawaguchi | T. Mizuta | T. Shirakawa | T. Honda | A. Komori | K. Nio | Hiroki Taguchi | A. Makiyama | M. Fukahori | F. Koga | N. Ureshino | Y. Ide | Y. Ueda | S. Otsu | T. Shibuki | J. Nakazawa